most of the studies cited support the hypothesis that an inhibition of cardiac converting enzyme may be involved in the beneficial hemodynamic and metabolic actions of converting enzyme inhibitors in cardiovascular disease , such as hypertension and congestive heart failure , independent of the circulating renin-angiotensin system .
C0007222
cardiovascular disease
C0020538
hypertension